Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

138
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
138
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

110
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
110
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

236
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
236
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

[Invasive mycoses in France: what are the trends?]

La Revue du praticien·2026
Same author

[Candidemia: the most frequent invasive fungal infection in France].

La Revue du praticien·2026
Same author

Antifungal exposure in <i>Scedosporium</i> septic arthritis: synovial penetration of voriconazole and terbinafine and plasma concentrations of olorofim.

Antimicrobial agents and chemotherapy·2026
Same author

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

The Journal of experimental medicine·2026
Same author

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same author

Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a prospective observational cohort study.

The Journal of infection·2026

Video Experimental Relacionado

Updated: Sep 8, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.7K

Aspergillus y la interacción huésped-patógeno: enfoque en aspectos relevantes para el tratamiento

Romain Manchon1, Simon Feys2, Martin Hoenigl3

  • 1Institut Pasteur, Université Paris Cité, Immunologie des Infections Fongiques, Paris, France; Infectious Diseases Department, Necker-Enfants Malades Hospital, Université Paris Cité, AP-HP, Paris, France.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
|September 5, 2025
PubMed
Resumen

La comprensión de la inmunidad del huésped en la aspergilosis invasiva (IA) es clave para desarrollar nuevos tratamientos. Las terapias inmunológicas personalizadas ofrecen esperanza para mejorar los resultados en pacientes inmunocomprometidos que enfrentan esta grave infección por hongos.

Más Videos Relacionados

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.4K
Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions
09:42

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Published on: May 16, 2020

4.2K

Videos de Experimentos Relacionados

Last Updated: Sep 8, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.7K
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.4K
Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions
09:42

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Published on: May 16, 2020

4.2K

Área de la Ciencia:

  • Inmunología
  • Enfermedades infecciosas
  • La farmacoterapia

Sus antecedentes:

  • La aspergilosis invasiva (IA) es una causa significativa de mortalidad en individuos inmunocomprometidos, especialmente en cuidados intensivos.
  • Los resultados subóptimos y la resistencia antifúngica requieren nuevas terapias complementarias dirigidas a los mecanismos inmunológicos del huésped.
  • La patogénesis de la IA implica respuestas inmunes complejas y heterogéneas a las especies de Aspergillus, principalmente Aspergillus fumigatus.

Objetivo del estudio:

  • Revisar las funciones de los componentes inmunes en las interacciones huésped-Aspergillus.
  • Para explorar nuevas terapias dirigidas a la inmunidad para la IA.
  • Para resaltar el potencial de la inmunoterapia personalizada.

Principales métodos:

  • Análisis exhaustivo de la literatura de estudios preclínicos y clínicos recientes.
  • Síntesis de la comprensión actual de la inmunopatogénesis de la IA.
  • Evaluación de las terapias inmunológicas como complemento del tratamiento antifúngico.

Principales resultados:

  • Las respuestas inmunes del huésped son complejas y heterogéneas, lo que complica el tratamiento uniforme.
  • Las terapias basadas en el sistema inmunológico son prometedoras como complementos de los medicamentos antifúngicos convencionales.
  • Están surgiendo enfoques personalizados adaptados a los perfiles inmunológicos.

Conclusiones:

  • Comprender la inmunidad del huésped en la IA es crucial para desarrollar estrategias terapéuticas precisas y personalizadas.
  • La inmunoterapia dirigida representa una frontera prometedora en el manejo de la IA y otras infecciones oportunistas.
  • Se necesita más investigación para traducir estos conocimientos en aplicaciones clínicas.